Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Aug 13;7(9):e00792.
doi: 10.1002/brb3.792. eCollection 2017 Sep.

Detection and application of neurochemical profile by multiple regional 1H-MRS in Parkinson's disease

Jitian Guan  1 , Yu Rong  1 , Ye Wen  2 , Huanze Wu  1 , Hong Qin  1 , Qingying Zhang  2 , Wei Chen  1
Affiliations

Detection and application of neurochemical profile by multiple regional 1H-MRS in Parkinson's disease

Jitian Guan et al. Brain Behav. .

Abstract

Introduction: The accurate diagnosis and monitoring of idiopathic Parkinson disease (PD), a progressive neurodegenerative disorder, has not been fully developed. This study sought to identify a neurochemical profile in multiple regions of the PD brain and healthy controls by proton magnetic resonance spectroscopy (1H-MRS). We aimed to track changes of the brain neurochemical, quantify neuronal loss, and further determine the diagnostic value of 1H-MRS.

Methods: PD patients and healthy controls recruited from Second Affiliated Hospital of Shantou University Medical College, Shantou, southern China, underwent 1H-MRS. Chemical information was obtained for ratios of N-acetylaspartate to creatine (NAA/Cr), NAA to choline (NAA/Cho), and Cho to Cr for substantia nigra, globus pallidus, prefrontal lobe, hippocampus, cuneus gyrus, and dorsal thalamus regions.

Results: Compared to the 20 healthy controls (12 male, age 58.75 ± 5.03 years), the 42 patients (21 male, age 61.60 ± 6.40 years) showed lower NAA/Cr and NAA/Cho ratios in substantia nigra, globus pallidus, prefrontal lobe, hippocampus, cuneus gyrus and dorsal thalamus regions (p < .01); NAA/Cr and NAA/Cho ratios were reduced for both patients with unilateral and mild/no cognitive impairment (p < .01); Unified Parkinson's Disease Rating Scale score was inversely correlated with NAA/Cr ratios in the substantia nigra (r = -.32; p = .042).

Conclusion: NAA/Cr and NAA/Cho ratios may be useful metabolic biomarkers for early diagnosis of PD. Multi-voxel 1H-MRS can provide information on brain neurochemistry and may be a promising technique for diagnosis of and monitoring neuronal loss in PD.

Keywords: N‐acetylaspartate (NAA); Parkinson's disease; proton magnetic resonance spectroscopy.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The regions of interest location on 1H‐MRS images (1, 2), dorsal thalamus (3, 4), globus pallidus (5, 6), substantia nigra (7, 8), hippocampus (9, 10), cuneus gyrus (11, 12)
Figure 2
Figure 2
1H‐MRS spectra obtained from a control subject (a) and a PD patient (b)
Figure 3
Figure 3
NAA/Cr ratios in substantia nigra, globus pallidus, prefrontal lobe, hippocampus, cuneus gyrus and dorsal thalamus for (a): healthy volunteers in left and right brain. (b): PD patients with unilateral impairment in the brain contralateral or ipsilateral to clinical sign and (c): PD patients with bilateral impairment in left and right brain
See this image and copyright information in PMC

References

    1. Abe, K. , Terakawa, H. , Takanashi, M. , Watanabe, Y. , Tanaka, H. , Fujita, N. , … Yanagihara, T . (2000). Proton magnetic resonance spectroscopy of patients with parkinsonism. Brain Research Bulletin, 52, 589–595. - PubMed
    1. Choe, B.‐Y. , Park, J.‐W. , Lee, K.‐S. , Son, B.‐C. , Kim, M.‐C. , Kim, B.‐S. , … Shinn, K. S . (1998). Neuronal laterality in Parkinson's disease with unilateral symptom by in vivo 1H magnetic resonance spectroscopy. Investigative Radiology, 33, 450–455. - PubMed
    1. Clarke, C. E. , & Lowry, M. (2000). Basal ganglia metabolite concentrations in idiopathic Parkinson's disease and multiple system atrophy measured by proton magnetic resonance spectroscopy. European Journal of Neurology: The Official Journal of the European Federation of Neurological Societies, 7, 661. - PubMed
    1. Dalrymple‐Alford, J. C. , MacAskill, M. R. , Nakas, C. T. , Livingston, L. , Graham, C. , Crucian, G. P. , … Anderson, T. J . (2010). The MoCA: Well‐suited screen for cognitive impairment in Parkinson disease. Neurology, 75, 1717–1725. https://doi.org/10.1212/WNL.0b013e3181fc29c9 - DOI - PubMed
    1. Dauer, W. , & Przedborski, S. (2003). Parkinson's disease: mechanisms and models. Neuron, 39, 889–909. - PubMed

LinkOut - more resources